CellAct Pharma GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2007-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.cellact.eu
Clinical Trials
2
Active:1
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors
Phase 2
Terminated
- Conditions
- Advanced Endstage Solid Carcinomas in Adults
- Interventions
- Drug: CAP7.1
- First Posted Date
- 2014-03-24
- Last Posted Date
- 2018-09-05
- Lead Sponsor
- CellAct Pharma GmbH
- Target Recruit Count
- 45
- Registration Number
- NCT02094560
- Locations
- 🇩🇪
Charite, University Hospital, Berlin, Germany
News
No news found